{
  "docId": "019de074-e81b-753e-9153-de7ee222684a",
  "docSlug": "eb349ec8590aecb3f4d8a8e322d8bfa8",
  "documentTitle": "Exscientia | Investor Presentation Deck | 45 slides",
  "authorId": "exscientia",
  "authorName": "Exscientia",
  "documentKindSlug": "conference-presentation",
  "documentKindLabel": "Conference presentation",
  "sourceTypeSlug": "investor_relations",
  "sourceTypeLabel": "Investor relations",
  "presentationDate": "2023-05-01 00:00:00",
  "orientation": "landscape",
  "aspectRatio": 1.7777778,
  "pageNumber": 24,
  "pageCount": 45,
  "prevPage": 23,
  "nextPage": 25,
  "slideType": "propose_solution",
  "function": "present_solution",
  "density": "overcrowded",
  "nDataPoints": 0,
  "notes": "The slide uses a three-column layout to define the core pillars of the drug development program.",
  "elementsJson": null,
  "metadataConfidence": 1,
  "imagePath": null,
  "slideHref": "/slides/019de074-e81b-753e-9153-de7ee222684a/24",
  "deckHref": "/decks/019de074-e81b-753e-9153-de7ee222684a",
  "deckJsonHref": "/decks/019de074-e81b-753e-9153-de7ee222684a.json",
  "deckAnchorHref": "/decks/019de074-e81b-753e-9153-de7ee222684a#slide-24",
  "components": [
    {
      "bbox": {
        "h": 0.12,
        "w": 0.28,
        "x": 0.67,
        "y": 0.75
      },
      "kind": "callout",
      "text": "Synergistic efficacy",
      "attrs": null,
      "subkind": "primary",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "989d5e00-219f-4868-9367-710fe0102c55",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.12,
        "w": 0.28,
        "x": 0.07,
        "y": 0.75
      },
      "kind": "callout",
      "text": "Goal was to invent a potent and highly selective allosteric MALT1 inhibitor",
      "attrs": null,
      "subkind": "primary",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "dbd2bd44-e20b-4804-a3c6-3a44cce3ea0e",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.12,
        "w": 0.28,
        "x": 0.37,
        "y": 0.75
      },
      "kind": "callout",
      "text": "Addresses a combination issue common to most MALT1i",
      "attrs": null,
      "subkind": "primary",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "df977e81-e528-46c0-8afa-068a272499b8",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.25,
        "w": 0.28,
        "x": 0.07,
        "y": 0.45
      },
      "kind": "list",
      "text": "Selective and Potent: Design a potent and highly selective MALT1 inhibitor with an allosteric mechanism of action; Clean protease panel selectivity profile",
      "attrs": null,
      "subkind": "bullet",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "212ac00f-f9b0-4be8-b9dc-0895617bc637",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.25,
        "w": 0.28,
        "x": 0.67,
        "y": 0.45
      },
      "kind": "list",
      "text": "Efficacy and Dosing: Shown to be effective as both a monotherapy and in combination with BTKi; Anti-proliferative against primary B-cell lymphoma samples; Predicted half-life suitable for QD administration",
      "attrs": null,
      "subkind": "bullet",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "c13af115-c1a4-43e2-8d50-03b4448e49b7",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.25,
        "w": 0.28,
        "x": 0.37,
        "y": 0.45
      },
      "kind": "list",
      "text": "Therapeutic Index: Demonstrate adequate therapeutic index over potential on-target toxicity; Minimise potential drug-drug interactions with combination agents",
      "attrs": null,
      "subkind": "bullet",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "fcbdae44-bcbf-4fff-a097-ab8cd9071b82",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.08,
        "w": 0.85,
        "x": 0.07,
        "y": 0.13
      },
      "kind": "paragraph",
      "text": "MALT1 protease inhibitor which activates the NF-κB pathway, resulting in uncontrolled proliferation of T- and B-cells in haematological cancers",
      "attrs": null,
      "subkind": "paragraph",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "b612826e-f08d-47ba-8790-9396e8257c35",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.05,
        "w": 0.5,
        "x": 0.07,
        "y": 0.06
      },
      "kind": "title",
      "text": "Precision design of an allosteric inhibitor",
      "attrs": null,
      "subkind": "headline",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "6208aaa2-a9c6-4c74-afd6-d42835f75c6e",
      "frameworkName": null,
      "frameworkSlug": null
    }
  ],
  "metrics": [],
  "tools": [],
  "frameworks": [],
  "arcBeats": [],
  "loops": [],
  "imagePathAlt": null,
  "thumbSrc": null,
  "thumbSrcAlt": null,
  "locked": true
}